Increased cerebral iron uptake in Wilson's disease: A Fe-52-citrate PET study

Toxicity of abundant copper is the main cause of brain and liver tissue dam age in patients with Wilson's disease (WD). However, there is also evidence of a disturbed iron metabolism in this genetically determined disorder. Th is PET study was undertaken to assess cerebral iron metabolism in WD patien ts. Methods: We used Fe-52-citrate, which converts to Fe-52-transferrin in blood plasma, to study basic pharmacokinetic features of the cerebral iron transport in 6 WD patients and in 16 healthy volunteers (control subjects). A 2-tissue-compartment model and multiple time graphic plotting were used to calculate Fe-52-transferrin distribution volumes and transport rates. Re sults: Net iron uptake (Ki) from plasma into brain tissue was significantly (P < 0.001) higher in WD patients (Ki [mean +/- SEM] = 15.1E-05 +/- 7.13E- 05 [1/min]) than in healthy volunteers (Ki = 2.66E-05 +/- 0.351E-05 [1/min] ). There was no difference of tracer iron distribution in the cerebral plas ma volume between patients and healthy volunteers. Iron uptake values resul ting from 2 methods to model PET data of patients and healthy volunteers we re highly correlated (P < 0.001). Conclusion: An abnormally increased cereb ral Fe-52-transferrin uptake was found in WD patients.